Latest Tables of Contents with Summaries

2021 Том 5, №1
Surgical treatment of pseudoaneurysm of the free left ventricle wall: a clinical case
O. Kiziukevich, S. Spiridonov, A. Zhyhalkovich, D. Isachkin
Today diseases of the cardiovascular system are the leading cause of death in many countries. The key role in this pathology is played by ischemic heart disease. An extreme manifestation of ischemic heart disease – myocardial infarction is one of the main causes of complications and mortality in patients with ischemic heart disease. One of the most formidable complications of acute myocardial infarction is heart rupture, which most often leads to death, more than 60% of cases occurring in the prehospital stage. Many studies of similar groups of patients show a wide spread in assessing the incidence and mortality of this pathology. The development of myocardial ruptures has two frequency peaks: the first day and 5–7 days from the onset of AMI. The most common case is acute rupture of the free wall of the left ventricle with extensive hemorrhage in the pericardium leading to a fulminant death. The development of a pseudoaneurysm of the left ventricle is a very rare outcome of the myocardial rupture.
Some aspects of clinical and laboratory parameters in newborns from mothers with coronavirus infection SARS-CoV-2 (COVID-19), infected at different times of perinatal period
I. Loginova, A. Ustinovich, E. Alferovich, I. Payuk, V. Shnitko
The problem of coronavirus infection has been the world’s concern since 2019. At the same time, the issues of infection of newborn children remain unclear, the issue of vertical transmission of the virus from mother to child is being discussed. The aim of our study was to study the features of the period of postnatal adaptation of newborns born to mothers with coronavirus infection SARS-CoV-2 (COVID-19), taking into account the time of infection occurrence. We analyzed the features of the neonatal course in children from the mothers with confirmed Covid-19 infection (PCR RNA of SARS-Cov 2) revealed in the mothers either during pregnancy or in the postpartum period. When examining children, we used clinical, laboratory, and biochemical research methods. It was found that children whose mothers contracted coronavirus infection COVID-19 immediately before childbirth had an aggravated course of the neonatal period compared with children from mothers who had recovered in the middle of pregnancy, and the manifestations of infection and post-hypoxic syndrome were more pronounced in the former. Laboratory investigations proved that newborns from the mothers who fell ill shortly before childbirth had acute viral inflammation.
Tetralogy of Fallot – «Old» congenital heart defect in the xxi century – unresolved questions of stage-by-stage surgical correction
P.F. Charnahlaz
Despite the fact that the defect has been known for a long time and methods of surgical correction have been developed that allow achieving excellent immediate and long-term results, the tactical issues of stage-by-stage correction of the defect in situations where primary radical correction is impossible due to such reasons as a severe initial condition, low weight of the patient, underdevelopment of the branches of the pulmonary artery (PA) have not yet been fully resolved. In addition to classical Blalock-Taussig intersystem anastomoses, such endovascular techniques of maintaining pulmonary blood flow as stenting of the right ventricular outflow tract (RVOT) and stenting of the patent ductus arteriosus (PDA) are being introduced into clinical practice. These techniques, with all the advantages of minimally invasive technologies in certain clinical and anatomical situations, are not inferior, and in most cases surpass classical surgical techniques.
Independent predictors and prognosis of long-term myocardial infarction in patients with unstable angina after coronary artery stenting
Miadzvedzeva Alena, Gelis Ludmila, Polonetsky Oleg, Russkikh Iryna
Objective. to develop independent predictors for predicting long-term myocardial infarction (MI) in patients (pts) with unstable angina (UA) after coronary artery stenting (PCI) based on the results of a seven-year follow-up. Materials and Methods. The study involved 165 pts with UA and coronary artery stenting (PCI). PCI was performed in 3.2±1.6 days after admission to the in-patient department. Drug-coated stents (Xience V and Biomatrix) were used, the average number of stents was 2.1±0.8 per person, the average length of the stented area was 43.12±25.6 mm, and the average diameter of the implanted stents was 3.12±0.5 mm. All patients were assessed for troponin I, myeloperoxidase, and C-reactive protein levels; coagulation hemostasis was assessed; and a thrombin generation test was performed. The aggregatogram was performed on the analyzer Multiplate (ASPI-test, ADP-test). The patients underwent echocardiography, coronary angiography. Double antithrombotic therapy with clopidogrel 75 mg and acetylsalicylic acid 75 mg was prescribed for 12 months. The follow-up period was 7.0±1.6 years.
Early and alternative markers of chronic heart failure in patients with diabetes mellitus
V. Vasilkova, T. Mokhort, L. Korotaeva, Y. Yarets, I. Pchelin, V. Bayrasheva, O. Shestovets, Y. Borovets, E. Naumenko, N. Filiptsova
Aim: to assess the relationship of proinflammatory cytokines and chemokines with the levels of natriuretic peptides in patients with diabetes mellitus (DM). Materials and methods. A total of 155 patients (14 men and 61 women) with type 1 and type 2 diabetes, aged 34 to 84 years, were examined. All patients underwent standard clinical and laboratory examination, with an assessment of the levels of pro-inflammatory cytokines (interleukin 6 (IL-6), tumour necrosis factor alpha (TNF-alpha), chemokines (monokine induced by interferon-gamma (MIG), regulated upon activation, normal T cell expressed and presumably secreted (RANTES), growth factors (fibroblast growth factor-23 (FGF-23), vascular endothelial growth factor (VEGF-A), natriuretic peptides (B‐type natriuretic peptide (BNP), N‐terminal fragment of B‐type natriuretic peptide (proBNP). Renal function was assessed based on the levels of serum creatinine, glomerular filtration rate (GFR), which was calculated according to the CKD-EPI formula, and albuminuria, which was assessed as albumin/creatinine ratio (A/C). An echocardiographic examination was conducted according to the standard protocol with the calculation of dimensional, volume and speed characteristics. Statistical data analysis was performed using smSTATA 14.2 for Mac (2018).
Prognostic factors of Wolff-Parkinson-White syndrome in children
E. Zasim, V. Strogiy
Objective: to determine the prognostic factors determining the severity of Wolff-Parkinson-White syndrome (WPW) in children. Methods: a retrospective analysis of the course of the disease was performed in 108 children with WPW syndrome aged 13.6 (12-16) years. Depending on the number of attacks of paroxysmal tachycardia (PT), all children were divided into 2 groups: group A consisted of 47 children (43.5%) with a history of no more than three attacks of PT and they were rare-group B included 61 children (56.5%) with frequent (more than once a month) attacks of PT, more than four in the history. We studied: the family history, the clinical picture of the disease, the nature of paroxysmal tachycardia, the effectiveness of treatment, and the results of instrumental studies. Using the method of mathematical modeling, the informative value of each feature was determined, and the diagnostic value was determined.
Clinical and functional features of the heart condition in patients with stable angina with concomitant bronchial asthma
T. Ilushina, N. Grigoryeva, K. Kolosova
Objective: to analyze the frequency of the combination of coronary heart disease (CHD) and bronchial asthma (BA) in clinical practice and to identify the features of the clinical course of stable angina in concomitant BA of varying severity.
Application of photomodification of blood using low-intensity optical radiation in the combination treatment of patients with unstable angina
O. Laskina, G. Zalesskaya, N. Mitkovskaya
The in vivo effect of low-intensity optical radiation (LIOR) on the blood of patients with unstable angina (UA) was studied. The integration of LIOR in the combined therapy of patients with UA proved to result in positive changes in the oxygen uptake system. Changes in the absorption spectra of the patients’ blood samples, blood oxygenation characteristics, and the proportion of metabolic products were studied at all stages of light exposure. The absorption of LIOR by the blood was found to lead to its photomodifica tion, which was manifested in changes of the partial pressure of blood gases, the content of oxyhemoglobin and the degree of saturation of hemoglobin with oxygen. LIOR affects the oxygen exchange in the body of patients with UA, changes the delivery and consumption of oxygen by tissues, initiates positive changes in the balance between the production of reactive oxygen intermediates, acting as physiologically active compounds, and their inhibition by antioxidant systems.
Positron emission tomography with 18F-FDG in the diagnosis of prosthetic heart valve endocarditis
A.S. Lukashevich
The purpose of the article is to evaluate the diagnostic significance of positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (18F-FDG PET/CT) for the diagnosis of prosthetic endocarditis.
Off-pump coronary artery bypass grafting without manipulation of the ascending aorta using a non-skeletonized great saphenous vein in patients with multivessel atherosclerotic coronary artery disease
A. Charniak, V. Podpalov, K. Rubakhov, O. Kozak, E. Troshin, A. Ostrovsky
Objective. To compare early postoperative hospital and one-year outcomes of coronary artery bypass grafting on a “working heart” (OPCABG) and coronary bypass grafting without manipulation of the ascending aorta (anCABG) in patients with multivessel atherosclerotic coronary artery disease.
Diagnostic signs of myocardial reperfusion injury after coronary artery bypass grafting
Shybekа Nаtallia, Gelis Lyudmila, Rusak Tatsiana
One of the main causes for operative mortality and perioperative complications after coronary artery bypass grafting is myocardial reper fusion injur y following the restoration of the coronar y circulation in the ischemic zone of the myocardium and characterized by myocardial, electrophysiological and vascular dysfunction. In order to identify the diagnostic signs of myocardial reperfusion injury after coronary artery bypass grafting, a prospective study was conducted, which included 89 patients with ischemic heart disease and forthcoming coronary artery bypass grafting either on-pump or off-pump. Postischemic myocardial dysfunction was assessed using transesophageal echocardiography, morphological and functional signs of myocardial reperfusion injury were detected using cardiac magnetic resonance imaging, moreover, the level of highly sensitive troponin, myoglobin, creatine phosphokinase-MB, metalloproteinase-2, and highly sensitive C-reactive protein was measured to assess the contribution of biomarkers to the development of reperfusion injuries. The obtained data allowed us to assess the morphological and functional characteristics of postischemic myocardial dysfunction and identify diagnostic signs of irreversible reperfusion injuries.
Anorexia syndrom as a determining factor for timely prevention of severe somatic complications of eating disorders
S. Shubina, O. Skugarevsky, S. Hunich
The research objective was to identify the differences in neurocognitive functioning and social cognition (emotional processing) in the presence of anorexia nervosa and schizophrenia, which will eventually help in developing methodological approaches and improving differential and diagnostic parameters to assess anorexia syndrome associated with these disorders.
Structural and functional left heart changes in the working age individuals with obstructive seep apnea syndrome (OSAS)
Е.К. Yushkevich, E.B. Petrova, N.P.Mitkovskaya
The aim of the study. To assess the echocardiographic signs of structural and left heart functional changes in the working age individuals with obstructive sleep apnea syndrome.
SARS CO-V-2 coronaviral infection in pregnant women (clinical data USE “6 City Clinical Hospital”)
L. Vasilyeva, E. Nikitina, S. Tsarova, L. Gulyaeva, V. Werbitzky
Аbstract: The article analyzes the features of the course of pregnancy in 110 women hospitalized in the Healthcare Institution “6th City Clinical Hospital” of Minsk for SARS CoV-2 coronavirus infection in April-October 2020. The authors studied the anamnestic data of pregnant women, analyzed the clinical data and the data from the instrumental and laboratory examinations of pregnant women with SARS CoV-2 coronavirus infection in the Republic of Belarus. A comparative analysis was carried out dealing with the treatment of pregnant women for coronavirus infection with SARS CoV-2 in a hospital setting.
Pancreatogenic morphostructural changes in the heart, lungs and other target organs in destructive pancreatitis
P. Koshevsky, S. Alekseyev, O. Popkov, V. Ginyuk, N. Bovtiuk
Introduction. Pathomorphological changes in destructive pancreatitis develop both in the pancreas and in various organs and tissues, it determining the clinical course and outcome of the disease. Most often in destructive pancreatitis, the cardiopulmonary system is affected, as well as the liver, kidneys, and brain. Damage to these target organs is one of the main elements of pathogenesis and thanatogenesis in destructive pancreatitis and is of interest not only for surgeons, but also for other clinical specialists, including cardiologists. Aim. To conduct a retrospective analysis of the most common morphostructural changes in the cardiopulmonary system and other target organs based on the results of autopsy reports of the deceased from destructive forms of acute and chronic pancreatitis and to identify the most characteristic morphostructural changes in the target organs.
Coronavirus infection (SARS-CoV-2): focus on COVID-19 associated coagulopathy
A.A. Pleshko, E.B. Petrova, S.V. Gunich, S.V. Rakovich, E.A. Grigorenko, N.P. Mitkovskaya
Officially announced by the World Health Organization (WHO) in March 2020, the coronavirus disease 2019 (COVID-19) pandemic is terrifying with the unimaginable rate of spreading and the large number of deaths. Morethan 171 million COVID-19 cases including more than 3,6 million deaths have been confirmed worldwide since the start of the pandemic. The high incidence of venous thromboembolic events and non-ARDS (acute respiratory distress syndrome) associated death of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, despite prophylactic antithrombotic therapy, may indicate the need for a more intensified personalized regime of preventive measures.
Justification of technologies for organizing medical care for patients with high cardiovascular risk on the example of the Brest region (Part 1)
N. Pabivantsava
In order to substantiate organizational measures for early detection and tertiary prevention of cardiovascular diseases, the causal relationships of high morbidity, disability, and mortality due to cardiovascular diseases, coronary heart disease and its complications were studied in the population of the Brest region in the period from 2006 to 2010. Measures to improve the organization of preventive medical examination of patients from cardiovascular risk groups with prognostically unfavorable outcomes were suggested. Through the implementation of an organizational experiment in 2012–2017, it was possible to achieve a positive medical and social effect, expressed in increasing the availability of multi-level and hightech care to patients in need, as well as in improving the medical and demographic indicators of the Brest region in general and in the diseases of the circulatory system in particular, which formed the basis of the second part of this article.
Implementation and evaluation of the effect of technologies for organizing medical care for patients with high cardiovascular risk on the example of the Brest region (part 2)
N.F. Pabivantsava, M.Yu. Surmach
The article shows how organizational measures were implemented to improve the organization of medical examinations of patients from cardiovascular risk groups with prognostically unfavorable outcomes on the example of the Brest region. By studying the health indicators of the region’s population before and after implementation, the paper analyzes the effectiveness of new organizational technologies. It is established that due to the adopted preventive measures at each territorial site and monitoring the patient’s route through databases from the district to the regional level of care, there is a decrease in the cardiovascular primary incidence, including coronary heart disease, with a significant decrease in the rate of acute conditions (acute coronary syndrome). The increase in prevalence indicates increased monitoring of all patients with circulatory diseases and coronary heart disease who were invited for conducting dynamic follow-up (dispensarization) in order to stratify the risks of their complications.
Exercise tolerance tests in the diagnosis of coronary heart disease, testing of patients with myocardial infarction and revascularization
L. Ushakova, E. Vertinsky, M. Shtonda, I. Semenenkov
Exercise tolerance test is one of the most commonly used non-invasive cardiac tests used to diagnose coronary heart disease, determine prognosis, and evaluate treatment. Treadmill test or bicycle ergometry allows determining how much more expensive and complex follow-up examination is necessary for the patient: myocardial perfusion scintigraphy with stress, stress echocardiography, multispiral computed tomography, as well as defining more clearly the indications for coronary angiography. The article presents modern ideas about a differentiated approach to performing exercise tolerance tests in patients with coronary heart disease, myocardial infarction, and revascularization.

Guidelines for Authors

The requirements for submitting scientific articles are based on the 'Unified Requirements for Manuscripts Submitted to Biomedical Journals' of the International Committee of Medical Journal Editors (the official version is available on the website www.ICMJE.org).

Submission of an article implies that the work described has not been previously published or already accepted for publication in other journals. The articles are published in Belarusian, Russian, and English. The articles which do not meet the 'Rules and Norms of Humane Treatment of Biological Objects of Research' are not accepted for publication. All articles submitted to the editorial office undergo multi-stage peer review, including verification by “Anti-plagiarism” system of automatic text checking for borrowings from the publicly available information sources. Comments of reviewers are sent to the author without specifying the names of reviewers. After receiving the reviews and the author’s reply, the editorial board makes a decision on publication (or rejection) of the article. The editors reserve the right to reject the article without stating reasons. The order and sequence of an article publication is determined depending on the volume of published materials and the list of sections in a particular issue. Minor corrections of stylistic, nomenclature and formal character are made without the author’s consent. If the article was processed by the author in the process of preparation for publication, the date of receipt is considered to be the day of the final text submission.

The Editorial Board of the journal 'Emergency Cardiology and Cardiovascular Risks' accepts the following types of articles:

1) original scientific materials and research data;
2) scientific reviews.

The electronic version of the article should be typed in Microsoft Word and printed on one side of the paper, Times New Roman font, 12. The font color is black. size 14 and 1,5 spaced in two copies. The width of the left margin is 3 cm, top and bottom – 2,5 cm, right – 1 cm. Portrait orientation. No hyphenation. Formatting is made in the 'width' parameter. Headings and subheadings are typed in bold with alignment to the left; no dot is placed at the end of the heading. No other text formatting is allowed in the article. One paragraph indent is left before the headings.

1 Article Structure

1.1 Article Description (in Russian)

1.1.1 UDC (Universal Decimal Classification) code

1.1.2 Initials and surnames of the author(s)

1.1.3 Title of the article

1.1.4 Official name of the organization where the authors work (superscript Arabic numerals indicate the institution)

1.1.5 Abstract in Russian (the volume for original research should be from 1800 to 2500 characters with spaces; and at least 1000 characters for review articles and descriptions of clinical cases). Original scientific research articles require structured abstracts: the purpose, methods, main results and conclusions of the work.

1.1.6 Keywords

1.2 Article Description (in English)

1.2.1 Initials and surnames of the author(s) (should correspond to the passport or be transliterated in the BSI system (British Standard Institute; UK, http://translit.ru/)

1.2.2 Title of the article

1.2.3 Official name of the organization where the authors work (superscript Arabic numerals indicate the institution)

1.2.4 Abstract in English (the volume for original research should be from 1800 to 2500 characters with spaces and at least 1000 characters for review articles and descriptions of clinical cases). The abstract is a brief summary of a research article and may be published as a separate entity.

The abstract must outline the most important aspects of the study. Abstracts should have a structured format (for original scientific articles: purpose, methods, results and conclusions). However, the subject, topic, purpose, method of research are given if they are new or of special interest. The text of the abstract should be clear and concise without any secondary information, general statements or complicated grammar structures.

References to the literature and abbreviations (except standard ones) are not allowed.

The results are stated precisely. The main theoretical and experimental findings, actual data, discovered relationships and patterns are given. Special emphasis should be placed on the new findings and the data having potential practical implication. 

The conclusions can be accompanied by recommendations, evaluations, suggestions, hypotheses, described in the article.

The abstract in English should not be a mere translation of the Russian version.

1.2.5 Keywords (according to MeSH).

2 Article Body

Depending on the type of the manuscript, the structure of the full text may be different.

The volume of original research and clinical cases descriptions, including figures, tables, literature index and summary should not exceed 30 thousand characters with spaces and that of reviews and lectures - 45 thousand characters with spaces.

Abbreviations are not allowed to be used, except for the chemical and common abbreviations, mathematical values, measurements and terms. The author of the article is to use the International System of Units (SI).

2.1 Original scientific articles

Original scientific articles contain the results of original research.

Sections of Original Scientific Article:

  • Introduction (not exceeding 2 pages) should state the topicality of the problem, including its significance (prevalence, morbidity, etc.) as well as mediated effects (social, economic). The solved and unsolved aspects of the problem should be identified with the analysis of previously published data.
  • Purpose of research;
  • Methods (the section should contain information on the design of the study, its duration, the method for evaluating the results, testing the hypothesis with describing the statistical methods and processing the results);
  • Results (description of the research content and main findings in detail; if necessary the section may be broken into subsections);
  • Discussion (the obtained results should be discussed from the point of view of novelty and compared with the known data);
  • Conclusion (should be presented in the form of a complete text);
  • Source of financing (specify the source of funding for the work);
  • Conflict of interests (presence of obvious and potential conflicts of interests, that is, conditions and facts that can influence the results of the research or their interpretation);
  • Expression of gratitude.

2.2 Scientific Review

The purpose of the review article should be a discussion of the accumulated material and the presentation of a new view of the author on previously described phenomena, a rethinking and search for new approaches to their interpretation, but not just listing the facts and stating the current state of the problem.

Sections of Scientific Reviews:

  • Introduction;
  • Discussion (may be presented as a separate section or run systematically through the text);
  • Conclusion (should be presented in the form of a complete text);
  • Source of financing (specify the source of funding for the analytical work);
  • Conflict of interests (presence of conflicts of interests, i.e. conditions and facts that can affect the results of the research or their interpretation);
  • Expression of gratitude.

3 References

Bibliographic index is placed at the end of the original article and should not contain more than 25 sources cited by the author. For scientific reviews it may be of no more than 50 sources in order of mention. In the text the author makes reference to the serial Index number in square brackets. Bibliographical description of the cited references should be in accordance with the requirements of the Higher Attestation Commission of the Republic of Belarus.

According to the requirements of international systems of citation the authors of the articles have to present references in the original language and in Latin alphabet. English references are identical to the ones transliterated to Latin alphabet.

4 Author information

The following elements must be included:

  • full names of all authors, their academic titles and degrees
  • postal address of the institution, the e-mail of each author and phone numbers

5 Tables

All the tables should be titled, numbered and self-explanatory. The data presented in tables should correspond to the numbers in the text but not duplicate results described elsewhere in the article. References to tables in the text are required. The titles of the tables and descriptions should be duplicated in English.

6 Illustrations

The quantity of graphics should be minimal.  Each illustration should have numbered picture captions. References to illustrations are required.  The titles of the figures and diagrams and their descriptions should be also duplicated in English. Links to figures in the text are required.

Illustrations (graphs, charts, drawings) performed in MS Office format should be contrast and clear. Illustrations should be performed in a separate file in*.jpeg, *.bmp, *.gif formats and placed in the article as fixed images. Do not use MS WORD to apply any elements on top of the inserted image (arrows, captions) due to the high risk of missing symbols during the editing and page make-up stages.

Photos, screenshots and other images should be embedded in the main text and also provided as separate files in *.jpeg, *.bmp, *.gif formats (*.doc and *.docx – in case of additional marks). The resolution of photographic images should be >300 dpi.

Each file should be titled and correspond to the image number in the text. In the file description picture captions should be placed and correspond to the name of the image embedded in the text.

The article should be submitted to the editor in the electronic version with the signatures of the authors. The article must be accompanied by a Letter of Application written in a free form.

Submission of an article for publication to 'Emergency Cardiology and Cardiovascular Risks' journal implies the consent of the author (s) with the published rules.

Address for letters
E-mail: emcardio@bsmu.by  

The order of reviewing article manuscripts submitted to the scientific and practical peer-reviewed journal “Emergency Cardiology and Cardiovascular Risks”

Manuscripts of all scientific articles submitted to the editors are subject to mandatory review by two independent experts. Review is carried out by the scientists who are recognized experts in the field of reviewed materials and work in the field of knowledge to which the content of the manuscript belongs and who have had publications on the subject of the article under review over the last three years.

The author, supervisor of a scientific degree scholar or coauthors of the reviewed work cannot be reviewers. The review of a scientific article is issued in accordance with the Memo to the reviewer of scientific articles and materials submitted to the journal “Emergency Cardiology and Cardiovascular Risks”.

Manuscripts are not considered for publication in case they do not meet the “Rules for Authors” which are published for convenience in the journal and its electronic version.

The editor informs the author about the review result by providing a copy of the review. The review contains recommendations for publication, correction and improvement of the article or a reasonable refusal. The author of the manuscript may take into account the recommendations when preparing a new version of the article or reasonably refute them. Articles refined by the author are resubmitted for review by a reviewer who made critical comments. The incoming date is considered to be the date of the refined article submission. If the author disagrees with the reviewer's comments, he may apply for a second review engaging a third expert or withdraw the article.

Articles and article reviews are discussed at the meeting of the editorial board, which serves as a basis to accept or reject an article. The decision of the editorial board is registered in by the protocol.

The order and priority of publications are determined depending on the volume of published materials and the list of subdivisions in a particular issue.

The editorial board does not guarantee the publication of all submitted materials. The article will not be accepted for consideration if it has been published or sent to other journals, the authors have not provided their complete personal data or the article does not meet the “Rules for Authors”. The editors reserve the right to edit the article without notifying the authors.

The final decision on the expediency of publications after their reviewing is made by the editorial board.

Articles not allowed for publication:

  • manuscripts which are not related to the scientific area of the journal;
  • manuscripts which do not meet the design requirements and their authors refuse to make their technical refinement;
  • manuscripts, the authors of which did not change the article according to the constructive requirements of the reviewer;

manuscripts, representing significant plagiarism due to copying data or conclusions from another author’s research without proper citation/reference (according to the recommendations of the World Association of Medical Editors (WAME) and COPE (Committee on Publication Ethics)); resubmission of the publication under the name of another author (in the original language or in translation); verbatim copying of more than 100 words from another (including his own) publication in the absence of a properly arranged quotation; unpublished borrowings of previously published ideas or hypotheses of other authors, and/or those that have not been tested by the “Anti-plagiarism” Automatic Text Checking System for borrowing from publicly available information sources.

If plagiarism is suspected:

the editorial board informs the experts and the author(s) of the material in writing about the initiation of the editorial investigation and its expected timeframe (2 months). Based on the results of the editorial investigation, a written statement is drawn up (stored in the editorial office), copies of which are provided to the person who discovered the fact of plagiarism and the author(s) about the decision made and the undertaken actions.

In case of insignificant plagiarism the editors of the journal must notify the author about the fact of plagiarism and obtain written explanations. If a violation by the author is qualified as unintentional, confine to a reprimand and sending a message about the inappropriateness of repeated cases. A revised manuscript with references to all original sources of borrowing may be published.

Manuscripts and electronic versions of both published and unpublished materials are not returned.

Reviews are kept in the editorial office for five years.

About Us

ISSN 2616-633X

Publishing semi-annual
Articles in Russian. Summaries in English

Address:

Dzerzhinski Ave., 83, Minsk, Republic of Belarus, 220116
Tel: +375 17 277-12-01.
Fax: +375 17 277-12-02
E-mail:  emcardio@bsmu.by
Web-site:  https://emcardio.bsmu.by

Editor-in-chief: Prof. Natalya P. Mitkovskaya, MD, PhD. Educational Institution «Belarusian State Medical University», Minsk, Belarus

Executive Secretary: Ekaterina B. Petrova, PhD Educational Institution «Belarusian State Medical University», Minsk, Belarus

Executive Editorial Office Secretary: Olga V. Laskina. Educational Institution «Belarusian State Medical University», Minsk, Belarus

 

Editor-in-chief greeting

 

Publication Ethics

Editorial Board

Sikorskij A.V., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Vojtovich T.N., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Gelis L.G., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Gubkin S.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Danilova L.I., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Dzjadz`ko A.M., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Karpov I.A., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kirkovkij V.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kozlovkij V.i., Grand PhD in Medical sciences, Professor (Vitebsk, Belarus)
Kopitov A.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Ostrovskij Ju.P. A.Yu., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Petrova M.N., PhD in Philological sciences, Associate Professor  (Minsk, Belarus)
Pristrom A.M., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Rudenko E.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Rudenok V.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Ruzanov D.Yu., PhD in Medical sciences, Associate Professor (Gomel, Belarus)
Salivonchik D.P., Grand PhD in Medical sciences, Professor (Gomel, Belarus)
Sidorovich E. K., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Sudzhaeva O.A., Grand PhD in Medical sciences (Minsk, Belarus)
Uss A.L., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Tsapaeva N.L., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Yanushko A.V., PhD in Medical sciences, Associate Professor (Grodno, Belarus)

 

Advisory Editorial Board

(International Consultative Committee)

Abel`skaya I.S., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Khryshchanovich V.Ya., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Azimferey Leonhard, Grand PhD in Medical sciences, Professor (Tîrgu Mureș, Romania)
Arutjunov G.P., Corresponding Member of the Russian Academy of Sciences , Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Bedel'baeva G.G., Grand PhD in Medical sciences, Professor (Almaty, Kazakhstan)
Beljaeva L.N., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Vismont F.I., Corresponding Member of the National Academy of Sciences o Belarus , Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Dzhunusbekova G.A., Grand PhD in Medical sciences, Professor (Almaty, Kazakhstan)
Drapkina O.M., Corresponding Member of Russian Academy of Sciences , Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Dudarenko S.V., Grand PhD in Medical sciences, Professor (St. Petersburg, Russian Federation)
Kamilova U.K., Grand PhD in Medical sciences, Professor (Tashkent, Uzbekistan)
Kibira Satoshi, Grand PhD in Medical sciences, Professor (Akita, Japan)
Koziolova N.A., Grand PhD in Medical sciences, Professor (Perm, Russian Federation)
Kostjuk William, Grand PhD in Medical sciences, Professor (London, Canada)
Krasnyj S.A., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kubarko A.I., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kul'chickij V.A., Corresponding Member of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Linn Tommi, Grand PhD in Medical sciences, Professor (Stockholm, Sweden)
Mrochek A.G., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Oganov R.G., Academician of the Russian Academy of Sciences,  Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Ostrovskij Ju.P., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Pershagen Joran, Grand PhD in Medical sciences, Professor (Stockholm, Sweden)
Pinevich D.L., First Deputy Minister of Health of the Republic of Belarus (Minsk, Belarus)
Rebrov A.P., Grand PhD in Medical sciences, Professor (Saratov, Russian Federation)
Rud Charls, Grand PhD in Medical sciences, Professor (Berkeley, USA)
Rummo O.O., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Skugarevskij O.A., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Snezhickij V.A., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Grodno, Belarus)
Sukalo A.V., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Tiffi Patrik, Grand PhD in Medical sciences, Professor (London, Canada)
Tret'jak S.I., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Fedoruk A.M., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Hirmanov V.N., Grand PhD in Medical sciences, Professor (St. Petersburg, Russian Federation)
Zhebentyayev A.I., Grand PhD in Pharmaceutical Sciences, Professor (Vitebsk, Belarus)
Gurina N.S., Grand PhD in Biological sciences, Professor (Minsk, Belarus)
Tsarenkov V.M., Grand PhD in Pharmaceutical Sciences, Professor (Minsk, Belarus)
Khishova O.M., Grand PhD in Pharmaceutical Sciences, Professor (Vitebsk, Belarus)
Kuznetsov V.A., Grand PhD in Medical sciences, Professor (Tyumen, Russian Federation)

 

Publishing Group

Balysh E. M., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Rachok L.V., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Volod'ko Ju.S., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Gerasimenok D.S., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Grigorenko E.A., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Mazanik Ju.N., (Minsk, Belarus)
Martusevich N.A., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Pyko A.A., PhD in Medical sciences (Minsk, Belarus)
Rustamov M.N., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Skakun L.N., (Minsk, Belarus)
Statkevich T.V., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Tenjushko E.S., (Minsk, Belarus)
Lanushevskaia A.V., (Minsk, Belarus)
Korzhenevskaia Iu.V., (Minsk, Belarus)
Tkachyova O.A., design, computer layout (Minsk, Belarus)
Vinokurov V.F., design, computer layout (Minsk, Belarus)
Zhuk L.I., editor (Minsk, Belarus)